BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33093511)

  • 1. Temporal trends in clozapine use at time of discharge among people with schizophrenia at two public psychiatric hospitals in Taiwan, 2006-2017.
    Lin CH; Chan HY; Hsu CC; Chen FC
    Sci Rep; 2020 Oct; 10(1):17984. PubMed ID: 33093511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schizophrenia patients discharged on antipsychotic polypharmacy from a public psychiatric hospital in Taiwan, 2006-2021.
    Lin CH; Huang CJ; Lin TC; Chan HY; Chen JJ
    Psychiatry Res; 2023 Dec; 330():115575. PubMed ID: 37913621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenia Patients Discharged on Clozapine Plus Long-Acting Injectable Antipsychotics From a Public Psychiatric Hospital in Taiwan, 2006-2021.
    Lin TC; Lin CH
    Int J Neuropsychopharmacol; 2023 Nov; 26(11):808-816. PubMed ID: 37616565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness.
    Barnes TR; Leeson VC; Paton C; Marston L; Davies L; Whittaker W; Osborn D; Kumar R; Keown P; Zafar R; Iqbal K; Singh V; Fridrich P; Fitzgerald Z; Bagalkote H; Haddad PM; Husni M; Amos T
    Health Technol Assess; 2017 Sep; 21(49):1-56. PubMed ID: 28869006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with laxative use in schizophrenia patients treated with second-generation antipsychotics.
    Lin CH; Chan HY; Hsu CC; Chen FC
    Eur Neuropsychopharmacol; 2021 Feb; 43():139-146. PubMed ID: 33419642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic agents used to augment clozapine during long-term inpatient hospitalizations.
    Leung JG; Chengappa KN; Ivanov E; Gandotra G; Kahn CE; Weber JS; Fabian TJ
    Pharmacopsychiatry; 2014 Nov; 47(7):263-7. PubMed ID: 25295551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of clozapine with amisulpride: an effective therapeutic strategy for violent treatment-resistant schizophrenia patients in a UK high-security hospital.
    Hotham JE; Simpson PJ; Brooman-White RS; Basu A; Ross CC; Humphreys SA; Larkin F; Gupta N; Das M
    CNS Spectr; 2014 Oct; 19(5):403-10. PubMed ID: 24284256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geographical and temporal variations in clozapine prescription for schizophrenia.
    Nielsen J; Røge R; Schjerning O; Sørensen HJ; Taylor D
    Eur Neuropsychopharmacol; 2012 Nov; 22(11):818-24. PubMed ID: 22503785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study.
    Bioque M; Parellada E; García-Rizo C; Amoretti S; Fortea A; Oriolo G; Palau P; Boix-Quintana E; Safont G; Bernardo M
    Eur Psychiatry; 2020 Jul; 63(1):e71. PubMed ID: 32669145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of clozapine with a second antipsychotic--a meta-analysis of randomized, placebo-controlled studies.
    Taylor DM; Smith L
    Acta Psychiatr Scand; 2009 Jun; 119(6):419-25. PubMed ID: 19245679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine.
    Conley RR; Love RC; Kelly DL; Bartko JJ
    Am J Psychiatry; 1999 Jun; 156(6):863-8. PubMed ID: 10360124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic polypharmacy and augmentation strategies prior to clozapine initiation: a historical cohort study of 310 adults with treatment-resistant schizophrenic disorders.
    Thompson JV; Clark JM; Legge SE; Kadra G; Downs J; Walters JT; Hamshere ML; Hayes RD; Taylor D; MacCabe JH
    J Psychopharmacol; 2016 May; 30(5):436-43. PubMed ID: 26905920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
    Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
    Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of clozapine initiation and cessation on psychiatric hospital admissions and bed days: a mirror image cohort study.
    Siskind D; Reddel T; MacCabe JH; Kisely S
    Psychopharmacology (Berl); 2019 Jun; 236(6):1931-1935. PubMed ID: 30715572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic prescribing for vulnerable populations: a clinical audit at an acute Australian mental health unit at two-time points.
    McMillan SS; Jacobs S; Wilson L; Theodoros T; Robinson G; Anderson C; Mihala G; Wheeler AJ
    BMC Psychiatry; 2017 Apr; 17(1):139. PubMed ID: 28407747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of aripiprazole augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study.
    Muscatello MR; Bruno A; Pandolfo G; Micò U; Scimeca G; Di Nardo F; Santoro V; Spina E; Zoccali RA
    Schizophr Res; 2011 Apr; 127(1-3):93-9. PubMed ID: 21262565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Augmentation of Clozapine With Paliperidone in Schizophrenia Patients With Partial Response to Treatment: A Case Series].
    Kalenderoğlu A; Çelik M
    Turk Psikiyatri Derg; 2016; 27(1):57-62. PubMed ID: 27369686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation with a second antipsychotic in patients with schizophrenia who partially respond to clozapine: a meta-analysis.
    Paton C; Whittington C; Barnes TR
    J Clin Psychopharmacol; 2007 Apr; 27(2):198-204. PubMed ID: 17414246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is antipsychotic augmentation associated with improved functioning in patients on clozapine?
    Cho JH; Mukherjee H; Sazhin V
    Australas Psychiatry; 2024 Jun; 32(3):186-191. PubMed ID: 38330162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of clozapine compared with conventional antipsychotic medication for patients in state hospitals.
    Essock SM; Frisman LK; Covell NH; Hargreaves WA
    Arch Gen Psychiatry; 2000 Oct; 57(10):987-94. PubMed ID: 11015817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.